PORRO, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 674
EU - Europa 427
AS - Asia 148
AF - Africa 22
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.276
Nazione #
US - Stati Uniti d'America 674
GB - Regno Unito 128
IT - Italia 69
CN - Cina 66
SE - Svezia 61
DE - Germania 60
SG - Singapore 56
RU - Federazione Russa 24
IE - Irlanda 22
IN - India 22
FR - Francia 20
UA - Ucraina 15
EE - Estonia 11
ZA - Sudafrica 10
CH - Svizzera 6
TG - Togo 6
CI - Costa d'Avorio 4
BG - Bulgaria 3
BE - Belgio 2
BR - Brasile 2
DK - Danimarca 2
NL - Olanda 2
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
NG - Nigeria 1
NO - Norvegia 1
SA - Arabia Saudita 1
SC - Seychelles 1
TR - Turchia 1
Totale 1.276
Città #
Fairfield 115
Southend 115
Chandler 59
Singapore 51
Ashburn 46
Santa Clara 39
Woodbridge 39
Wilmington 38
Seattle 33
Cambridge 29
Houston 27
Ann Arbor 24
Princeton 24
New York 23
Dublin 22
Bologna 15
Boardman 14
Bremen 12
Saint Petersburg 11
Westminster 11
Medford 10
Nanjing 10
Dearborn 9
Jacksonville 6
Lomé 6
Berlin 5
Padova 5
San Diego 5
Abidjan 4
Changsha 4
Jinan 4
Bolzano 3
Hebei 3
Kunming 3
Pune 3
Redwood City 3
Shanghai 3
Shenyang 3
Sofia 3
Taizhou 3
Tianjin 3
Bern 2
Brussels 2
Chengdu 2
Florence 2
Guangzhou 2
Jiaxing 2
Milan 2
Moscow 2
Nanchang 2
Norwalk 2
Olalla 2
São Paulo 2
Abeokuta 1
Ardabil 1
Baoding 1
Beijing 1
Buffalo 1
Castelfidardo 1
Den Haag 1
Des Moines 1
Falls Church 1
Fermo 1
Foshan 1
Frankfurt Am Main 1
Frattamaggiore 1
Fuzhou 1
Groningen 1
Hangzhou 1
Las Vegas 1
Munich 1
Mülheim 1
Orange 1
Oslo 1
Phoenix 1
Pignone 1
Quito 1
Radeberg 1
San Francisco 1
Shenzhen 1
Suzhou 1
Tallinn 1
Washington 1
Wuxi 1
Xi'an 1
Xuzhou 1
Zhengzhou 1
Totale 903
Nome #
The future of dual therapy for hepatitis C virus 166
IL28 polymorphism and HCC after DAAs for chronic hepatitis C 127
Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma 126
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 111
P.09.6 IL28 POLYMORPHISM AND HCC DEVELOPMENT AFTER DAAS FOR CHRONIC HEPATITIS C 108
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 99
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. 99
null 96
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis 93
Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis 91
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 79
Indocyanine green clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis. 70
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 54
Totale 1.319
Categoria #
all - tutte 3.593
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.593


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020160 0 0 0 0 0 0 46 39 36 15 11 13
2020/2021140 30 14 6 4 6 4 6 9 22 14 9 16
2021/2022281 11 6 17 16 23 9 7 16 9 18 111 38
2022/2023224 25 29 12 36 18 22 8 9 42 5 14 4
2023/202477 1 13 1 10 4 34 5 0 4 3 0 2
2024/2025155 17 47 26 15 42 8 0 0 0 0 0 0
Totale 1.319